HIV Vaccine Trials Network
From Wikipedia, the free encyclopedia
The HIV Vaccine Trials Network (HVTN) is a non-profit organization which connects physicians and scientists with activists and community educators for the purpose of conducting clinical trials seeking a safe and effective HIV vaccine. Collaboratively, researchers and laypeople review potential vaccines for safety, immune response, and efficacy. The HVTN is a network for testing vaccines, and while its members may also work in vaccine development for other entities, the mission of the HVTN does not include vaccine design.[1]
![]() | |
Company type | Non-profit organization |
---|---|
Industry | HIV vaccine research |
Headquarters | Seattle, Washington |
Key people | Lawrence Corey, Lead PI |
Website | http://www.hvtn.org |
The HVTN is the only HIV vaccine research network sponsored by the American government. It also manages the only large-scale HIV vaccine research trial network in Africa.[2] The HVTN collaborates with the Division of Acquired Immunodeficiency Syndrome (DAIDS). Funding comes from the National Institute of Allergy and Infectious Diseases and National Institutes of Health,[3] which oversee DAIDS. HVTN is headquartered at the Fred Hutchinson Cancer Research Center in Seattle.[4] The vaccines being tested come from various producers, both commercial and non-profit.[5]